These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15548159)

  • 61. Gonadotrophin-releasing hormone agonist triggering may improve central oocyte granularity and embryo quality.
    Lan KC; Chen YC; Lin YC; Tsai YR
    Zygote; 2020 Aug; 28(4):337-343. PubMed ID: 32241315
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
    Fisch JD; Keskintepe L; Sher G
    Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prevention of multiple pregnancy by induction of single ovulation].
    Aono T
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):666-71. PubMed ID: 8808834
    [No Abstract]   [Full Text] [Related]  

  • 65. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists.
    Kolibianakis EM; Papanikolaou EG; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Hum Reprod; 2006 Apr; 21(4):1012-7. PubMed ID: 16339166
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IVF conversion to IUI in poor responders: an observational study.
    Freour T; Dubourdieu S; Mirallie S; Langlois ML; Jean M; Barrière P
    Arch Gynecol Obstet; 2010 Oct; 282(4):445-9. PubMed ID: 20499076
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The probability of successful IVF outcome after poor ovarian response.
    Saldeen P; Källen K; Sundström P
    Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.
    Corifollitropin Alfa Dose-finding Study Group
    Hum Reprod; 2008 Nov; 23(11):2484-92. PubMed ID: 18684735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Kallmann syndrome: report of a pregnancy case and review of the literature].
    Loret de Mola Gutierrez JR; Lee CS
    Ginecol Obstet Mex; 1992 Jul; 60():197-200. PubMed ID: 1398199
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
    Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
    Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of gonadotropin-releasing hormone antagonists in poor responders.
    Mahutte NG; Arici A
    Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early cleavage does not predict treatment outcome following the use of GnRH antagonists in women older than 35.
    Yang WJ; Hwu YM; Lee RK; Li SH; Lin SY; Fleming S
    Fertil Steril; 2007 Dec; 88(6):1573-8. PubMed ID: 17555755
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The combination of urinary and recombinant HCG improves outcome in patients with decreased oocyte/follicle ratio in previous cycles.
    Littman ED; Milki AA
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):60-2. PubMed ID: 12818445
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of human chorionic gonadotropin as a replacement for gonadotropin-releasing hormone in ovulation-synchronization protocols before fixed timed artificial insemination in beef cattle.
    Burns MG; Buttrey BS; Dobbins CA; Martel CA; Olson KC; Lamb GC; Stevenson JS
    J Anim Sci; 2008 Oct; 86(10):2539-48. PubMed ID: 18539821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A study to determine whether serum follicle-stimulating hormone can be a marker for ovarian hyperresponse to follicle-maturing drugs for in vitro fertilization.
    Check JH; Pesso R; Peymer M
    Gynecol Obstet Invest; 1997; 43(4):242-4. PubMed ID: 9194622
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders.
    Nikolettos N; Al-Hasani S; Felberbaum R; Demirel LC; Kupker W; Montzka P; Xia YX; Schopper B; Sturm R; Diedrich K
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):202-7. PubMed ID: 11451549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of pure follicle stimulating hormone during the luteal phase to increase success of ovulation induction in poor responders: a pilot study.
    Trott EA; Chakraborty S; Russell JB
    Del Med J; 1998 May; 70(5):249-51. PubMed ID: 9635346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.